期刊文献+

大鼠胰高血糖素样肽-1受体的克隆和原核表达 被引量:1

Cloning and Prokaryotic Expression of Rat Glucagon Like Peptide-1 Receptor
下载PDF
导出
摘要 目的从大鼠胰岛细胞INS-1中克隆胰高血糖素样肽-1受体(GLP-1R)的编码序列,构建原核表达载体并在大肠埃希菌中表达。方法培养INS-1细胞,提取细胞总RNA,经RT-PCR技术扩增出GLP-1受体的编码序列。然后将其连接到原核表达载体pGEX-4T-1中,并进行酶切、测序鉴定。将获得的pGEX-4T-1-GLP-1R转化大肠埃希菌感受态细胞BL21(D3),经异丙基硫代-β-D-半乳糖苷(IPTG)诱导后收集菌体蛋白,最后通过SDS-PAGE对收获的融合蛋白进行鉴定。结果成功获得了GLP-1R编码序列,构建了原核表达载体pGEX-4T-1-GLP-1R并在大肠埃希菌BL21(D3)中表达。表达的融合蛋白主要存在于上清液中,分子量大小约为83kD。结论本实验为获取GLP-1R大量蛋白样品制备抗体提供了可能;GLP-1R的克隆也为建立2型糖尿病的新药筛选平台提供了条件。 Objective To clone the cDNA of glucagon like peptide-1 receptor (GLP-1R) from the INS-1 ceils and express the protein in E. call Mter constructing the prokaryotic expression vector pGEX-4T-1-GLP-1R. Methods The full length cDNA of GLP-1R was cloned by RT-PCR from the total RNA of INS-1 cells, and then inserted into the vector pGEX-4T-1. After identified by two restriction endonucleases and DNA sequencing, the prokaryotic expression vector pGEX-4T-1-GLP-1R was transSected into BL2I (D3). The fusion protein GLP-1R/GST was obtained via IPTG inducing, and then confirmed by SDS- PAGE which showed the expected band. Results The coding sequence of GLP-1R has been cloned into pGEX-4T-1 vector and expressed in BL21 (D3) successfully. The fusion protein expressed mainly existed in the supernatant with a molecular weight of 83 kD. Conclusion This study would make it possible to prepare large amounts of protein samples and produce GLP-1R anti- body. The cloning of GLP-1R also makes it possible to create an approach to screen the new drugs of 2-DM.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2009年第3期401-404,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 国家"973"计划项目(No.2006CB503907) 科技部专项基金(No.2004CCA01400) 国家自然科学基金(No.30870989)资助项目
关键词 胰高血糖素样肽-1受体 克隆 原核表达 glucagon like peptide-1 receptor clone prokaryotic expression
  • 相关文献

参考文献10

  • 1DOYLE M E, EGAN J M. Mechanisms of action of glucagon-like peptide 1 in the pancreas[J]. Pharmacol Ther, 2007, 113(3): 546-593.
  • 2GALLWITZ B. New therapeutic strategies for the treatment of type 2 diabetes mellitus based on incretins[J].Rev Diabet Stud, 2005, 2(2): 61-69.
  • 3HAY C W, SINCLAIR E M, BERMANO G, et al. Glucagon-like peptide-1 stimulates human insulin promoter activity in part through cAMP-responsive elements that lie upstream and downstream of the transcription start site[J].J Endocrinol, 2005, 186(2): 353-365.
  • 4PERFETTI R, ZHOU J, DOYLE M E, et al. Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats EJ]. Endocrinology, 2000, 141(12):4600-4605.
  • 5WIDEMAN R D, YU I L, WEBBER T D, et al. Improving function and survival of pancreatic islets by endogenous production of glucagon-like peptide 1 (GLP-1)[J].Proc Natl Acad Sci USA, 2006, 103(36): 13468-13473.
  • 6KLINGER S, POUSSIN C, DEBRIL M B, et al. Increasing GLP-1-induced beta-cell proliferation by silencing the negative regulators of signaling cAMP response element modulator-alpha and DUSP14[J].Diabetes, 2008, 57(3): 584- 593.
  • 7FARILLA L, BULOTTA A, HIRSHBERG B, et al. Glueagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets[J]. Endocrinology, 2003, 144(12): 5149-5158.
  • 8RANGANATH L R. The entero-insular axis: implications for human metabolism[J]. Clin Chem Lab Med, 2008, 46 (1) :43-56.
  • 9CHEPURNY O G, HUSSAIN M A, HOLZ G G. Over-expression of the glueagon-like peptide-1 receptor on INS-1 cells confers autocrine stimulation of insulin gene promoter activity: a strategy for production of pancreatic beta-cell lines for use in transplantation[J]. Cell Tissue Res, 2002, 307(2) : 191-201.
  • 10AHREN B, GOMIS R, STANDL E, et al. Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes[J]. J Clin Endocrinol Metab, 2004, 89(5) : 2078-2084.

同被引文献11

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部